Capital return moves put Morgan Stanley in focus

Morgan Stanley (MS) has drawn investor attention after its board approved a higher quarterly dividend and a large new share repurchase authorization, putting capital returns at the center of the current stock story.

The recent dividend hike and US$20.0b buyback authorization come after a strong run in Morgan Stanley’s stock, with a 90 day share price return of 28.65% and a 1 year total shareholder return of 53.93%, while the 7 day share price return of 6.77% indicates some cooling in short term momentum.

If this focus on capital return has you thinking more broadly about where money is flowing, it can be helpful to widen your lens and check out 20 top founder-led companies

With Morgan Stanley shares up strongly over the past year and trading close to analyst targets while still showing an intrinsic value premium, the key question now is whether investors are overlooking further upside or whether the market is already pricing in future growth.

Most Popular Narrative: 7.9% Undervalued

Compared with the last close of $211.72, the most followed narrative puts Morgan Stanley’s fair value at $230, suggesting a modest valuation gap that hinges on how its growth drivers play out.

The firm's advanced deployment of AI, data analytics, and end-to-end digital tools across self-directed, adviser-led, and workplace channels is described as poised to significantly reduce operating costs and boost advisor productivity. This is expected to support sustained margin expansion and outsized earnings leverage if digital client engagement compounds over time.

Want to see what kind of revenue expansion and margin profile this implies for Morgan Stanley? The fair value case leans heavily on compounding fee income and a richer earnings mix, presented as a long term growth and valuation framework that some investors are using as a reference point.

Result: Fair Value of $230 (UNDERVALUED)

However, this upside narrative for Morgan Stanley can be knocked off course if fee pressure from low cost platforms intensifies or if major acquisitions underperform expectations.

Another way to look at Morgan Stanley's value

While the popular fair value narrative suggests Morgan Stanley is 7.9% undervalued at $230 per share, our DCF model points in the opposite direction. On this view, the stock trades above an estimated future cash flow value of $181.89, which implies a premium rather than a discount. For investors, that kind of gap raises a simple question: which story deserves more weight in your process?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Morgan Stanley for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 42 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Given the mix of optimism and concern around Morgan Stanley, it makes sense to move quickly, test the assumptions against the underlying data, and shape your own view with the help of 4 key rewards and 3 important warning signs

Looking for more investment ideas beyond Morgan Stanley?

If Morgan Stanley has sharpened your focus on quality and valuation, do not stop here. Broaden your watchlist now or you risk missing other compelling setups.

• Target potential mispricing by scanning companies that look attractively valued on quality metrics through the 42 high quality undervalued stocks.
• Strengthen your income stream with stocks that combine higher yields and resilience by reviewing the 9 dividend fortresses.
• Dial down portfolio risk by focusing on companies with sturdy financial foundations using the solid balance sheet and fundamentals stocks screener (48 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.